Navigation Links
The trouble with hybrids

Hybrid electric vehicles that run on both conventional gasoline and stored electricity can be no more than a stop gap until more sustainable technology is developed, according to researchers in France. Writing in the Inderscience publication International Journal of Automotive Technology and Management, they suggest that the adoption of HEVs might even slow development of more sustainable fuel-cell powered electric vehicles.

Jean-Jacques Chanaron Research Director within the French National Centre for Scientific Research (CNRS) and Chief Scientific Advisor at the Grenoble School of Management and Julius Teske at Grenoble, question strongly whether the current acceptance of hybrid vehicle technology particularly in the USA is in any way environmentally sustainable.

The researchers have analyzed the spread of this technology including the non-financial drivers for its adoption. They point out that most manufacturers are rapidly integrating hybrid electric vehicles into their technology portfolio, despite the absence of significant profitability.

They add that the misinformed craze for hybrid vehicles especially in the USA, and increasingly in Japan and Europe, and potentially in China, could represent a red light for more innovative technologies, such as viable fuel-cell cars that can use sustainably sourced fuels, such as hydrogen. They concur with earlier studies that suggest that hydrogen fuel cells will not be marketable in high volumes before at least 2025. This could, however, be too late for some models of climate change and emissions reduction. They also point out that even fuel cell technology has its drawbacks and much of the marketing surrounding its potential has emerged only from the hydrogen lobby itself.

"There is a general convergence of strategies towards promoting hybrid vehicles as the mid-term solution to very low-emission and high-mileage vehicles," the researchers assert, "this is largely due to Toyotas strategy of learning the technology, while building up its own quasi-standard, thanks to its high-quality and reliability reputation and its high market share on the North American market." They add that, "Such a convergence is based more on customer perception triggered by very clever marketing and communication campaigns than on pure rationale scientific arguments and may result in the need for any manufacturer operating in the USA to have a hybrid electric vehicle in its model range in order to survive."

Moreover, political pressures also play a significant part. The three major US manufacturers - GM, Ford, and Chrysler - recently urged President Bush to financially and politically support a national technological solution for hybrids; this was independent of the currently dominant solutions initiated by Toyota. The researchers concede that, "The quest for low emission, clean, and high-mileage vehicles is on its way and should be at the top of the manufacturers' agenda," they say. However, they suggest that the technology, marketing, and public perception leads to one overriding problem: Is a hybrid strategy sustainable in the long run? Chanaron and Teske think not.

The complexity and high cost of the hybrid technology is also playing against itself," they say, "There is a huge strategic dilemma for the key players of the automotive industry where a mistake in technology decision-making might turn even a big player into a take-over candidate. The next five years will provide industry observers with more accurate trends and success or failure factors."


Contact: Albert Ang
Inderscience Publishers

Related medicine news :

1. 9/11 Exposure Linked to Behavior Trouble in Kids
2. Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
3. Urinary dysfunction troubles men who undergo prostate removal
4. Caffeine Could Spell Trouble for Diabetics
5. New Colon Cancer Test Might Spot Trouble Earlier
6. Peripheral Arterial Disease Costlier to Treat Than Heart Trouble
7. Holiday Travel, Bad Eating Habits a Recipe for Stomach Trouble
8. Abdominal Fat Tied to High Risk for Coronary Trouble
9. Vioxx Ban Tied to Rise in Serious GI Trouble
10. Early Weight Gain Can Mean Heart Trouble Later in Life
11. Trouble deciding?
Post Your Comments:
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology: